Clinical Trials Logo
  1. Home
  2. Contact Lens Complication
  3. NCT02298400
  4. Details
NCT02298400 Clinical Trial

A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses

Contact Lens Complication Clinical Trial

Official title:
A Single-Center, Cross-over, Pilot Study Evaluating Acuvue® Oasys® Lenses (Senofilcon A), 30-Day Bausch + Lomb PureVision (Balafilcon A), and Clariti® 1-Day (Somofilcon A) Lenses, for Their Impact on Ocular Discomfort Induced by Exposure to the Turbo Controlled Adverse Environment™

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT02298400
Other study ID # 14-270-0001
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date September 2014

Study information
Verified date April 2024
Source ORA, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the comfort of three commercially available contact lenses.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be at least 18 years old - Have provided written informed consent - Have discomfort when wearing contact lenses Exclusion Criteria: - Have an active ocular infection or significant slit lamp findings - Participated in any other studies in the past 30 days

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Acuvue® Oasys® Lenses (senofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
• 30-Day Bausch + Lomb PureVision (balafilcon A)
Contact lenses placed in each eye during the day for about 8 hours
• Clariti® 1-Day (Somofilcon A)
Contact lenses placed in each eye during the day for about 8 hours

Locations
Country Name City State
United States Andover Eye Associates Andover Massachusetts

Sponsors (1)
Lead Sponsor Collaborator
ORA, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Contact lens wear comfort, as assessed by subject reported symptoms in diaries. 1 week
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05036954 - Observational Study on the Efficacy and Tolerance of EYEBRID Lenses
Recruiting NCT04163328 - Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort Phase 4
Recruiting NCT06052046 - Total30 for Astigmatism Contact Lenses N/A
Completed NCT04663529 - Correlation Study of Corneal Nerve Changes and Dry Eye in Contact Lens Wearers
Recruiting NCT06256770 - Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia
Completed NCT03848221 - Direct Application of Systane Complete to Contact Lenses Phase 4
Completed NCT05239494 - Dailies Total 1 Sphere Contact Lenses N/A
Active, not recruiting NCT06266728 - T30 for Astigmatism in Digital Device Users N/A
Recruiting NCT05290727 - Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort N/A
Completed NCT04806763 - Myopia Control With Orthokeratology Contact Lenses in Spain N/A
Completed NCT05183022 - Total30 Sphere Contact Lenses N/A
Withdrawn NCT03408015 - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Phase 4
Completed NCT03305484 - Soft Contacts Observation of Risk and Education (SCORE)
Completed NCT03566680 - Treating Contact Lens Discomfort With Orthokeratology N/A
Completed NCT03525704 - Evaluation of Contact Lens Saline Solutions With Scleral GP Contact Lens Wearers Experiencing Fogging N/A
Recruiting NCT06392438 - Cyclosporine and Intense Pulsed Light for Dry Eye in Contact Lens Users Phase 3